TRPX - Therapix Biosciences Ltd.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
-0.2100 (-12.50%)
At close: 4:00PM EST

1.8200 +0.35 (23.81%)
Pre-Market: 8:59AM EST

Stock chart is not supported by your current browser
Previous Close1.6800
Bid1.6400 x 1300
Ask1.7200 x 1300
Day's Range1.4500 - 1.6500
52 Week Range1.4000 - 8.0000
Avg. Volume80,683
Market Cap6.486M
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-2.7980
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est18.00
  • CNW Group

    SOL Global Portfolio Company Heavenly Rx, Ltd. Enters Into MOU for Business Combination with Therapix Biosciences

    TORONTO, Nov. 19, 2019 /CNW/ - SOL Global Investments Corp. ("SOL Global" or the "Company") (CSE:SOL.CN - News) (OTCPK:SOLCF - News) (Frankfurt:9SB.F - News) announced today that its 40.7% owned portfolio company Heavenly  Rx, Ltd. ("Heavenly Rx") has entered into a memorandum of understanding ("MOU") with the US NASDAQ listed public company, Therapix Biosciences Ltd (NASDAQ:TRPX - News), a speciality clinical-stage pharmaceutical company with a portfolio of technologies and assets based on cannabinoid pharmaceuticals, pursuant to which Therapix and Heavenly Rx have agreed to pursue a business combination. Pursuant to the MOU, the parties will negotiate a definitive agreement for a business combination between Therapix and Heavenly Rx, constituting a reverse takeover of Therapix by Heavenly Rx.

  • Market Exclusive

    Cannabis Stock News Weekend Roundup December 23

    Cannabis News On Dec. 20, President Trump signed the Agriculture Improvement Act of 2018 into law, legalizing hemp in the U.S. Among other things, this new law changes certain federal authorities relating to the production and marketing of hemp, defined as cannabis (Cannabis sativa L.), and derivatives of cannabis with extremely low (less than 0.3% […] The post Cannabis Stock News Weekend Roundup December 23 appeared first on Market Exclusive.

  • We're sorry this is all we were able to find about this topic.